DK1578738T3 - Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf - Google Patents

Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1578738T3
DK1578738T3 DK03779759T DK03779759T DK1578738T3 DK 1578738 T3 DK1578738 T3 DK 1578738T3 DK 03779759 T DK03779759 T DK 03779759T DK 03779759 T DK03779759 T DK 03779759T DK 1578738 T3 DK1578738 T3 DK 1578738T3
Authority
DK
Denmark
Prior art keywords
preparation
escitalopram hydrobromide
escitalopram
hydrobromide
Prior art date
Application number
DK03779759T
Other languages
English (en)
Inventor
Robert Dancer
Lawrence Martel
Hans Petersen
Peter Ellegaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1578738(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of DK1578738T3 publication Critical patent/DK1578738T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
DK03779759T 2002-12-23 2003-12-18 Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf DK1578738T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23
PCT/DK2003/000902 WO2004056791A1 (en) 2002-12-23 2003-12-18 Escitalopram hydrobromide and a method for the preparation thereof

Publications (1)

Publication Number Publication Date
DK1578738T3 true DK1578738T3 (da) 2008-06-30

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03779759T DK1578738T3 (da) 2002-12-23 2003-12-18 Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf

Country Status (33)

Country Link
US (1) US20040167209A1 (da)
EP (1) EP1578738B1 (da)
JP (2) JP4658613B2 (da)
KR (1) KR20050086933A (da)
CN (1) CN100349885C (da)
AR (1) AR042652A1 (da)
AT (1) ATE388947T1 (da)
AU (1) AU2003287919B2 (da)
BR (1) BR0317623A (da)
CA (1) CA2511142A1 (da)
CY (1) CY1107451T1 (da)
DE (1) DE60319739T2 (da)
DK (1) DK1578738T3 (da)
EA (1) EA013116B1 (da)
EG (1) EG24729A (da)
ES (1) ES2298595T3 (da)
HK (1) HK1087708A1 (da)
IL (1) IL169125A0 (da)
IS (1) IS2654B (da)
ME (1) MEP5808A (da)
MX (1) MXPA05005772A (da)
MY (1) MY135468A (da)
NO (1) NO20053595L (da)
NZ (1) NZ540281A (da)
PE (1) PE20040924A1 (da)
PL (1) PL378275A1 (da)
PT (1) PT1578738E (da)
RS (1) RS51092B (da)
TW (1) TW200501943A (da)
UA (1) UA80170C2 (da)
UY (1) UY28148A1 (da)
WO (1) WO2004056791A1 (da)
ZA (1) ZA200504109B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
MXPA05005772A (es) * 2002-12-23 2005-08-16 Lundbeck & Co As H Bromhidrato de escitalopram y un metodo para su preparacion.
NZ549100A (en) * 2004-03-05 2010-02-26 Lundbeck & Co As H Crystalline composition containing escitalopram oxalate
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7569605B2 (en) * 2005-10-14 2009-08-04 Forest Laboratories Holdings Limited Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
KR20080075113A (ko) * 2005-10-14 2008-08-14 하. 룬트벡 아크티에 셀스카브 에스시탈로프람 및 부프로피온을 함유하는 안정한 약학적제형
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
EP2042499B1 (en) * 2006-07-11 2018-06-27 Mitsubishi Tanabe Pharma Corporation Salt of a morpholine compound
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
PL3694843T3 (pl) * 2017-10-09 2022-06-20 Hasleton, Mark Nowa sól i nowe stałe postacie escitalopramu
EP4277661A1 (en) 2021-01-18 2023-11-22 Anton Frenkel Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
KR100411505B1 (ko) * 1998-10-20 2003-12-18 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
EA002801B1 (ru) * 1999-10-25 2002-10-31 Х.Лундбекк А/С Способ получения циталопрама
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
EP1339816B1 (de) * 2000-12-04 2004-08-11 Westfalia Separator AG Verfahren zur vorbehandlung von rohölen und rohfetten für eine herstellung von fettsäureestern
MEP5908A (xx) * 2001-05-01 2010-02-10 Lundbeck & Co As H Upotreba enantiomerno čistog escitaloprama
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
MXPA05005772A (es) * 2002-12-23 2005-08-16 Lundbeck & Co As H Bromhidrato de escitalopram y un metodo para su preparacion.
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
JP4658613B2 (ja) 2011-03-23
EP1578738A1 (en) 2005-09-28
KR20050086933A (ko) 2005-08-30
IS2654B (is) 2010-08-15
AU2003287919B2 (en) 2009-11-12
PL378275A1 (pl) 2006-03-20
CN1726202A (zh) 2006-01-25
MEP5808A (xx) 2010-02-10
BR0317623A (pt) 2005-11-29
CN100349885C (zh) 2007-11-21
RS51092B (sr) 2010-10-31
ATE388947T1 (de) 2008-03-15
AR042652A1 (es) 2005-06-29
PE20040924A1 (es) 2004-12-11
MY135468A (en) 2008-04-30
EP1578738B1 (en) 2008-03-12
TW200501943A (en) 2005-01-16
JP2011037893A (ja) 2011-02-24
UY28148A1 (es) 2004-09-30
HK1087708A1 (en) 2006-10-20
ES2298595T3 (es) 2008-05-16
EG24729A (en) 2010-06-21
EA013116B1 (ru) 2010-02-26
JP2006514952A (ja) 2006-05-18
IL169125A0 (en) 2009-02-11
UA80170C2 (en) 2007-08-27
RS20050487A (en) 2007-06-04
WO2004056791A1 (en) 2004-07-08
IS7848A (is) 2005-05-17
DE60319739T2 (de) 2008-07-17
MXPA05005772A (es) 2005-08-16
US20040167209A1 (en) 2004-08-26
AU2003287919A1 (en) 2004-07-14
PT1578738E (pt) 2008-04-11
NO20053595L (no) 2005-09-05
CA2511142A1 (en) 2004-07-08
EA200501046A1 (ru) 2005-12-29
NZ540281A (en) 2008-07-31
DE60319739D1 (de) 2008-04-24
ZA200504109B (en) 2006-08-30
CY1107451T1 (el) 2012-12-19

Similar Documents

Publication Publication Date Title
NO2015010I1 (no) Everolimus - se vedlegg til søknad
DK1206495T3 (da) Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
BRPI0313238A2 (pt) método
NO20035697D0 (no) 5-HT-reseptor-ligander og anvendelser derav
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
DK1620551T3 (da) Phospholipase og fremgangsmåde til fremstilling deraf
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
IS2654B (is) Essítalópram hýdróbrómíð og aðferð til framleiðslu þess
DK1354224T3 (da) Sensorindretning, fremgangsmåde til dens fremstilling og anvendelse
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20051875D0 (no) Kjoleror og fremgangsmate for bruk av dette
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
DE60316781D1 (de) Aufgussbeutel
DK1518827T3 (da) Krystalliseret IM-12-faststof og fremgangsmåde til fremstilling heraf
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DK1568280T3 (da) Fremgangsmåde til fremstilling af fermenteret mælk og fermenteret mælk
DK1359593T3 (da) SPM-sensor og fremgangsmåde til dens fremstilling
DK1639107T3 (da) Forbedrede proteaser og fremgangsmåder til fremstilling deraf
NO20014376D0 (no) Anordning, fremgangsmåte og anvendelse
DK1261625T3 (da) Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse